TARK Biopharma Co., Ltd., established in 2020, is dedicated to developing innovative new molecular entities (NMEs) to address unmet clinical needs. Leveraging artificial intelligence technology, we accelerate the drug development process, advancing from preclinical research to clinical stages. Our mission is to provide more effective treatment options for patients worldwide, enhancing their quality of life.
兆益生醫 (TARK Biopharma Co., Ltd.) 成立於2020年，致力於研發創新新分子實體（new molecular entities, NME）藥物，以解決臨床未滿足的醫療需求。我們運用人工智慧技術加速新藥開發流程，從臨床前研究推進至臨床階段，致力於為全球患者提供更有效的治療方案，提升生活品質。
Company Details
- Founded
- -
- Address
- 新北市, Tw
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Lotus Pharmaceutical Co..
- HQ
- 新北市
Tark Biopharma Questions
Tark Biopharma's LinkedIn profile is https://tw.linkedin.com/company/tark-biopharma
Tark Biopharma's industry is
Biotechnology Research
Tark Biopharma's top competitors are
Icr Centre For Protein Degradation,
Lotus Pharmaceutical Co., Ltd,
Welbloom Biotech 逢興生技,
Cancerfree Biotech,
Enlightmen Biotech.
Tark Biopharma's categories are Biotechnology Research
Tark Biopharma's founding year is 2020
